Triple Flag (TFPM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Hinge Health's strong partnerships, high client retention, and integration with major health plans drive predictable revenue and market expansion. Learn more on HNGE stock here.

PepsiCo’s stock jumped 7% on July 17 after a robust Q2 earnings announcement. The company not only surpassed expectations but ...

Clover Health is growing Medicare Advantage and improving margins, but ongoing losses and unproven tech keep upside limited.

Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in ...

Rainwater Equity Portfolio Manager Joseph Shaposhnik likes the stocks of companies in aerospace parts, stock exchanges, and software that can weather most economic conditions.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.82, a high estimate of ...

Analysts have set 12-month price targets for CG Oncology, revealing an average target of $60.0, a high estimate of $75.00, and a low estimate of $41.00. This current average has decreased by 7.93% ...